Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fentanyl 400micrograms/dose nasal spray
0407020A0AABPBP
|
Fentanyl | Fentanyl | Central Nervous System | 10 |
|
Gabapentin 500mg/5ml oral liquid
0408010G0AAAVAV
|
Gabapentin | Gabapentin | Central Nervous System | 10 |
|
Galantamine 12mg tablets
0411000F0AAACAC
|
Galantamine | Galantamine | Central Nervous System | 10 |
|
Hydromorphone 2mg/1ml solution for injection ampoules
040702050AAALAL
|
Hydromorphone hydrochloride | Hydromorphone hydrochloride | Central Nervous System | 10 |
|
Lorazepam 5mg/5ml oral liquid
0401020P0AABJBJ
|
Lorazepam | Lorazepam | Central Nervous System | 10 |
|
Ontozry 150mg tablets
0408010ANBBACAC
|
Ontozry | Cenobamate | Central Nervous System | 10 |
|
Palexia 75mg tablets
0407020AGBBABAB
|
Palexia | Tapentadol | Central Nervous System | 10 |
|
Pitolisant 4.5mg tablets
0404000W0AAABAB
|
Pitolisant hydrochloride | Pitolisant hydrochloride | Central Nervous System | 10 |
|
Raponer XL 8mg tablets
0409010H0BGACAM
|
Raponer XL | Ropinirole hydrochloride | Central Nervous System | 10 |
|
Rodomel XL 75mg capsules
0403040W0BCAAAD
|
Rodomel | Venlafaxine | Central Nervous System | 10 |
|
Solian 400 tablets
0402010A0BBACAE
|
Solian | Amisulpride | Central Nervous System | 10 |
|
Tapentadol 100mg modified-release capsules
0407020AGAAAKAK
|
Tapentadol | Tapentadol | Central Nervous System | 10 |
|
Topiramate 100mg/5ml oral suspension
040801050AAAZAZ
|
Topiramate | Topiramate | Central Nervous System | 10 |
|
Vigabatrin 100mg soluble tablets sugar free
0408010X0AABLBL
|
Vigabatrin | Vigabatrin | Central Nervous System | 10 |
|
Alli 60mg capsules
0405010P0BCAAAB
|
Alli | Orlistat | Central Nervous System | 9 |
|
Apozyl 10mg orodispersible tablets
0411000D0BCABAE
|
Apozyl | Donepezil hydrochloride | Central Nervous System | 9 |
|
Cabaser 1mg tablets
0409010U0BBAAAA
|
Cabaser | Cabergoline | Central Nervous System | 9 |
|
Chloral hydrate 500mg/5ml oral solution sugar free
0401010B0AABTBT
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 9 |
|
Chlordiazepoxide 5mg tablets
0401020E0AAAAAA
|
Chlordiazepox hydrochloride | Chlordiazepoxide hydrochloride | Central Nervous System | 9 |
|
Co-dydramol 10mg/500mg/5ml oral solution
0407010N0AAACAC
|
Co-dydramol | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 9 |
|
Diamorphine 500mg powder for solution for injection ampoules
0407020K0AAAGAG
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 9 |
|
Dihydrocodeine 10mg/5ml oral solution
0407020G0AAAAAA
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 9 |
|
Domperidone 30mg suppositories
0406000J0AAABAB
|
Domperidone | Domperidone | Central Nervous System | 9 |
|
Effentora 800microgram buccal tablets
0407020A0BKAEBG
|
Effentora | Fentanyl | Central Nervous System | 9 |
|
Fentanyl 1.2mg lozenges
0407020A0AAANAN
|
Fentanyl | Fentanyl | Central Nervous System | 9 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.